Methods:Serum CA125 in patients with ovatian cancer,benign ovarian tumor and normal controls were measured by elctrochemi luminescence immuno-assay(ECLIA).

• 方法:运用电化学发光免疫测定法对卵巢癌患者、卵巢良性肿瘤患者血清CA125进行测定,另选取健康体检人群作为对照。